| Tag | Content |
|---|
EnhancerAtlas ID | HS175-15012 |
Organism | Homo sapiens |
Tissue/cell | SK-N-MC |
Coordinate | chr2:128242460-128244120 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr2:128242574-128242595 | AAAGAAAAAGAAAAAGAAAAA | - | 6.17 | | IRF1 | MA0050.2 | chr2:128242580-128242601 | AAAGAAAAAGAAAAAGAAAAA | - | 6.17 | | ZNF263 | MA0528.1 | chr2:128242673-128242694 | GAAAGAGGAGGGAGAGAGAGA | + | 6.42 | | ZNF263 | MA0528.1 | chr2:128242676-128242697 | AGAGGAGGGAGAGAGAGAGGA | + | 7.91 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_19088 | chr2:128242521-128244610 | CD4p_CD25-_Il17-_PMAstim_Th |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 128243244 | 128243463 | | chr2 | 128242789 | 128243206 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I127484 | chr2 | 128242522 | 128244610 |
|
Enhancer Sequence | TAACTGGGAG GCTGAGGCAG GAGAATGGTG TGAACCCAGG AGGCGGAACT TGCAGTGAGT 60
GGAGATCGCA CCACTGCACT CCAACCTGGG CGACAGAGCA AGACTCCGTC TCAAAAAGAA 120
AAAGAAAAAG AAAAAGAAAA AGGACAGAAG GGCAAAAAAG AAACAGGTAC AGGGGACATG 180
GAGAGGTGGT CAGGGACACG GATATGGGCA CAAGAAAGAG GAGGGAGAGA GAGAGGAGGA 240
AGTTCTTGGC ACAGAACTAG TCCTTCTCTA CCCTCGATTT ATTCTCAAGA AATAAGAAAG 300
TACGTTTTGT TTTGATAGTC ACTTAATAGC AACATGAACT GGCAGGTAGG AGAGTGGAGT 360
CAGTGGAAAC AGCTGCCAAA GCAGGGGTCA TGGAGAAGAA CCATAGGCAG GCAACACACA 420
CACACTGTGT GTGCTCCGCA ACAAAGGTGC CATTAGTCTC AAAGCATAGT GGATCAGTGA 480
GTTGGGCTTA TGAATGTTCC CAAGTCTTTT CCACTTCTGA CCACATTTTG AGTATGTGTT 540
AATCAAATTC ATCTCCTAAA TATTTAGTAT AAGGCTTTAT GTAATGAGTT CTCAAATGCA 600
TGTTGCTGAG CCACTGACAG CAGGAAACAA GCTACCTCCC ACCAGGAAAC CACTAACTAG 660
TTTATATGCC TGTAACACAT ATCACTGTAA TTCTGGGTCC TAACAAAAAC CTTTTTCATA 720
AAAACGGGTA CCAGTCAGGA AGACCCAAAT GCATATTAGG GAAGTAATTA TCTATTACTC 780
TCTAGGATAC TGATAAAGGA AGGGACTTCC ATGTCAATTT CTAAATATTC AAGAGGCCTT 840
GAATATCCCA AGGTGCCTGT TAGGGTCATT ATTTTGAAAC TAAAAGCAGA CCTGGCCTCT 900
TCTGATTAAG AAAGCACACA CACACACACT TTTCACTCTG ACTGTTGACA ATTCAAGCCC 960
ATGCACAGTA CATGCTTCCT TGGGAATACC TCTCGTGTAT ATACTCTGGT AGGGCCAGGC 1020
CTATAGGGGC ATCCTGTTGC CTTCAATGCT GAACTTGACA GCACGATGCA CTTTGCTGAG 1080
TCGTTTCTGT TCTGCAAATC GCCTCTTATG CTTTTCCAAT CGGCTTAGGC CCTTTTTAAG 1140
AATACCAGGC TAGAAGTAGT AGTTTGATTG GAGAATAAAA AGAGATTACT GAGAAACACT 1200
GAAGATCCAC TGAGCAGTAT TTACAATGAT AACAGAATAA GTGTCTACCC TAATCATTTG 1260
CAATGGAATT GCTTAAACCG TTGAAGAGAA AGGGAGAGGT AGGTCTGCTG AAGCACGTAA 1320
GCTCTGTTTC TCATGGTTAT TAAAAAAAAA AATTCACTGT ATCAGAATAC TCCAGGTTTC 1380
AATTTCAAGC CTTGCTTGAA GTAAAGGGAT TAATAAGAAG AAACTTCCCT ACCTGATAAT 1440
GTTGAATTAA GACTGAAGAA AAATTCATCA GCAATAAACT TTAATCCTGG GTAATACTTT 1500
TCCTTTCTCT ATTGCTCAAT TTGTGGTTTG GCTAGATAAG CGACCAGAAA ACAGTCCTCT 1560
CTGAATCAGA CAAACTTCAA GAGCTACAAG GGTTATTAAC ACATGAAGTA AAGAGTCAAA 1620
CAGTAATCTG CAGGTGAGAT CCACCTTGCC GATCCTCCGC 1660
|
